NCQA updates medical home standards

New standards for patient centered medical homes (PCMHs) focus on behavioral health, care management for high-needs populations and team-based care, among other updates.

The National Committee for Quality Assurance (NCQA) updated the most widely adopted way of organizing and evaluating PCMHs by releasing the latest generation of NCQA medical home standards, PCMH 2014.

NCQA uses the standards to assess primary care practices seeking NCQA PCMH Recognition. This release is the third iteration of the NCQA medical home program since 2008. Currently, over 10 percent of U.S. primary care practices—more than 35,500 clinicians at more than 7,000 practice sites—have earned NCQA PCMH Recognition. Many insurers pay higher reimbursement rates to practices that have earned the NCQA PCMH seal.

Changes affecting the advantages and requirements of NCQA PCMH Recognition include the following:

  • Integration of behavioral health: Expectations rise, as they did in previous NCQA standards, that a practice support patients’ behavioral health. Practices are expected to collaborate with behavioral healthcare providers and to communicate behavioral healthcare capabilities to patients.
  • Care management focus on high-need populations: Practices are expected to address socioeconomic drivers of health and poorly controlled or complex conditions. Practices also should focus on the special needs of patients referred from the “medical neighborhood” of practices that surround and inform the medical home.
  • Enhanced emphasis on team-based care: Revised standards emphasize collaboration with patients as part of the care team and establish team-based care as a “must-pass” criterion for NCQA Recognition.
  • Alignment of improvement efforts with the triple aim: Practices must show that they are working to improve across all three domains of the triple aim: patient experience, cost and clinical quality.
  • Sustained transformation: In keeping with the goal of continuous improvement, practices show that they comply with NCQA standards over long periods.
Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.